Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » Microcide Spinoff Gains $12.5 Million Funding

Microcide Spinoff Gains $12.5 Million Funding

Dec 21, 1998
Premium

MOUNTAIN VIEW, Calif.-- Microcide Pharmaceuticals here has formed Iconix Pharmaceuti cals, a chemical genetics company aimed at extending the company's microbial genomics research into a broader technology platform. The new entity has acquired a $12.5 million venture investment from Abingworth Management, Institutional Venture Partners, and Kleiner Perkins Caufield & Byers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Italy Seeks to Manufacture Vaccines

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

Fetal Tissue Research Restrictions Reversed

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

Funds for Viral Genomic Surveillance

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

PLOS Papers on Aicardi-Goutières Syndrome, COVID-19 in Colombian Amazon, Cancer MicroRNAs

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.

Apr
28
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Integrative Analysis of Single-Cell Omics and Imaging Data

Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development. 

May
04
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Transcriptome-Guided Analysis of Highly Multiplexed Immunohistochemistry Images

Sponsored by
Akoya Biosciences

Recently developed technologies for digital imaging and highly multiplexed immunohistochemistry (mIHC) advancing the field of histology into a quantitative era, allowing for more complex descriptions of tissue architecture.

May
06
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Enriching Spatial Proteomic Data with Parallel CITE-seq Analysis Elucidates Multiomic Changes with Aging

Sponsored by
Akoya Biosciences

Integrating complementary data sets provides a powerful tool to study complex biological processes.

May
11
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Panel Discussion: Analysis Strategies for Enriching Single-Cell Spatial Phenotyping Data

Sponsored by
Akoya Biosciences

Our expert panelists will review their own strategies for addressing the challenges of integrative multiomic analysis and will share best practices for this rapidly evolving field.

What's Popular?

In Informatics

  1. Biden Administration Commits $1.7B to SARS-CoV-2 Variant Sequencing, Surveillance

  2. Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery

    Premium

  3. French Single-Cell Analysis Startup Minos Biosciences Raises €1.5M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.